Macenat Jean-Robert MD is categorized under Internal Medicine Doctors in Bronx, NY and active since 2010.
Macenat Jean-Robert MD was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Jean-Robert Macenat at the company’s single location by writing to 769 Concourse Village West, Bronx, New York NY 10451 or by phoning (718) 402-4021. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Macenat Jean-Robert MD |
| Contact Person: | Jean-Robert Macenat |
| Address: | 769 Concourse Village West, Bronx, New York 10451 |
| Phone Number: | (718) 402-4021 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Macenat Jean-Robert MD was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Jean-Robert Macenat for inquiries that concern Macenat Jean-Robert MD by calling the company number (718) 402-4021, as your correspondence is most welcome. Additionally, the physical location of the single location of Macenat Jean-Robert MD can be found at the coordinates 40.82442,-73.92267 as well as the street address 769 Concourse Village West in Bronx, New York 10451.
For its online presence, you may visit Macenat Jean-Robert MD’s website at and engage with its social media outlets through on Twitter and on Facebook.